Legacy Pharmaceutical Packaging LLC recalls Sertraline Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
- Products
-
- Sertraline Tablets
- Company
- Legacy Pharmaceutical Packaging LLC
- Where it was sold
-
CA and AR
States: Arkansas, California
- Units affected
- 161,664 bottles
- About this recall
- Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54